Shakeel, L., Shaukat, A., & Akilimali, A. (2025). Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD). Wiley.
Chicago Style (17th ed.) CitationShakeel, Laiba, Ayesha Shaukat, and Aymar Akilimali. Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD). Wiley, 2025.
MLA (9th ed.) CitationShakeel, Laiba, et al. Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD). Wiley, 2025.
Warning: These citations may not always be 100% accurate.